Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of GI Cancer Trial

March 12, 2018

Responsive image

REDWOOD CITY, Calif., March 12, 2018 /PRNewswire/ — The Guardant360® assay, the leading comprehensive liquid biopsy, will be used to launch a new arm of a nationwide trial run by SCRUM-Japan GI-SCREEN, organized by the National Cancer Center Hospital East (NCCE), Kashiwa, Japan. The…

Category: Precious Metals